Photodynamic Therapy (PDT) with Chemotherapy for Advanced Lung Cancer with Airway Stenosis.

Abstract

Intractable advanced lung cancer can be treated palliatively with photodynamic therapy (PDT) combined with chemotherapy to remove central and peripheral (lobar or segmental bronchi) bronchial stenosis and obstruction. We present data for 12 (eight men, four women) consecutive patients with 13 advanced non-small cell lung carcinomas in whom curative operations were contraindicated, who underwent PDT combined with chemotherapy for local control of the intraluminal lesions. The mean age was 73.3 years (range, 58-80 years), and the stages of cancer were IIA-IV. The median stenosis rates before treatment, one week post-treatment, and one month post-treatment were 60% (range, 30%-100%), 15% (range, 15%-99%), and 15% (range 15%-60%), respectively. The mean and median survival times were 9.3 and 5.9 months, respectively. The overall 1-year survival rate was 30.0%. No PDT-related morbidity or mortality occurred. In this single-institution study, all patients experienced improved symptoms and quality of life at one week after treatment; furthermore, an objective response was evidenced by the substantial increase in the openings of the bronchial lumen and prevention of obstructive pneumonia. Therefore, PDT with chemotherapy was useful and safe for the treatment of bronchial obstruction.

• Authors: Masakazu Kimura, Kuniharu Miyajima, Masakazu Kojika, Takafumi Kono, Harubumi Kato
• Journal: International journal of molecular sciences (Int J Mol Sci) Vol. 16 Issue 10 Pg. 25466-75 (Oct 23 2015) ISSN: 1422-0067 [Electronic] Switzerland
• PMID: 26512656 (Publication Type: Clinical Trial, Journal Article)

Topics

• Aged
• Aged, 80 and over
• Airway Obstruction (drug therapy, etiology)
• Carcinoma, Non-Small-Cell Lung (complications, drug therapy, pathology)
• Constriction, Pathologic (drug therapy, etiology, therapy)
• Female
• Humans
• Male
• Middle Aged
• Photochemotherapy (adverse effects)